0001209191-23-050695.txt : 20230927
0001209191-23-050695.hdr.sgml : 20230927
20230927192050
ACCESSION NUMBER: 0001209191-23-050695
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230917
FILED AS OF DATE: 20230927
DATE AS OF CHANGE: 20230927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ruiz Roger Richard
CENTRAL INDEX KEY: 0001993970
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38935
FILM NUMBER: 231285826
MAIL ADDRESS:
STREET 1: C/O ATRECA, INC.
STREET 2: 835 INDUSTRIAL ROAD, SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atreca, Inc.
CENTRAL INDEX KEY: 0001532346
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273723255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-595-2595
MAIL ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-09-17
0
0001532346
Atreca, Inc.
BCEL
0001993970
Ruiz Roger Richard
C/O ATRECA, INC.
835 INDUSTRIAL ROAD, SUITE 400
SAN CARLOS
CA
94070
0
1
0
0
VP of Finance
Class A Common Stock
34980
D
Employee stock option (right to buy)
3.18
2031-12-22
Class A Common Stock
25000
D
Employee stock option (right to buy)
1.845
2031-01-26
Class A Common Stock
28250
D
Employee stock option (right to buy)
1.49
2033-02-08
Class A Common Stock
50000
D
Employee stock option (right to buy)
1.845
2028-10-29
Class A Common Stock
41666
D
Employee stock option (right to buy)
1.845
2029-01-30
Class A Common Stock
8333
D
Employee stock option (right to buy)
1.845
2030-02-25
Class A Common Stock
27000
D
Consists of 26,647 shares of Class A Common Stock and 8,333 restricted stock units pertaining to a restricted stock unit award granted on February 9, 2023, vesting in three equal annual installments beginning on August 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Each restricted stock unit represents a right to receive one share of Class A Common Stock upon vesting.
1/48 of the Option vests in equal monthly installments as measured from December 1, 2021, subject to the Reporting Person providing continuous service to the Issuer as of each such date. If applicable, vesting accelerates as provided in,
and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
1/48 of the Option vests in equal monthly installments as measured from January 1, 2021, subject to the Reporting Person providing continuous service to the Issuer as of each such date. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
The Board of Directors of the Issuer approved a repricing of this Option, effective June 13, 2022.
1/48 of the Option vests in equal monthly installments as measured from January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of each such date. If applicable, vesting accelerates as provided in,
and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
Fully vested.
1/48 of the Option vests in equal monthly installments as measured from January 1, 2020, subject to the Reporting Person providing continuous service to the Issuer as of each such date. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
/s/ Roger Richard Ruiz
2023-09-27
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of John A. Orwin, Courtney Phillips, Danielle Naftulin and John T. McKenna,
signing individually, the undersigned's true and lawful attorneys-in fact and
agents to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director or beneficial owner of more than 10% of a registered
class of securities of Atreca, Inc. (the "Company"), Forms 3, 4 and 5 (including
any amendments thereto) in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") and the rules thereunder
and a Form ID, Uniform Application for Access Codes to File on EDGAR;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to execute such Forms 3, 4 or 5 or Form ID
(including any amendments thereto) and timely file such forms with the United
States Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact is no longer employed by the Company
or Cooley LLP.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of September 27, 2023.
/s/ Roger Richard Ruiz